Selected research
Market Outlook & Growth Opportunities
Global Membrane Technology in Pharmaceutical Market Outlook and Growth Opportunities 2026
Market perspective
Global Membrane Technology in Pharmaceutical key players include Cytiva, Merck Millipore, Pall Corporation, etc. Global top 3 manufacturers hold a share over 38%.
North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share about 49 percent.
In terms of product, Microfiltration is the largest segment, with a share over 39%. And in terms of application, the largest application is Pharmaceutical.
Read the full market overview
This report provides an overview of the global Membrane Technology in Pharmaceutical market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Membrane Technology in Pharmaceutical and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Membrane Technology in Pharmaceutical revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Membrane Technology in Pharmaceutical market.
Membrane Technology in Pharmaceutical Segment by Company
Cytiva
Merck Millipore
Pall Corporation
3M
Sartorius Group
Thermo Fisher Scientific
DuPont
Parker Hannifin
Koch Separation Solutions
Amazon Filters
Advantec
Microdyn-Nadir
Membrane Solutions
Membrane Technology in Pharmaceutical Segment by Type
Microfiltration
Ultrafiltration
Nanofiltration
Reverse Osmosis
Others
Membrane Technology in Pharmaceutical Segment by Application
Pharmaceutical
Biopharmaceutical
Life Science
Membrane Technology in Pharmaceutical Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Membrane Technology in Pharmaceutical status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Membrane Technology in Pharmaceutical key companies, revenue, market share, and recent developments.
3. To split the Membrane Technology in Pharmaceutical breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Membrane Technology in Pharmaceutical market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Membrane Technology in Pharmaceutical significant trends, drivers, influence factors in global and regions.
6. To analyze Membrane Technology in Pharmaceutical competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Membrane Technology in Pharmaceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Membrane Technology in Pharmaceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Membrane Technology in Pharmaceutical.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Membrane Technology in Pharmaceutical industry.
Chapter 3: Detailed analysis of Membrane Technology in Pharmaceutical company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Membrane Technology in Pharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Membrane Technology in Pharmaceutical in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Microfiltration
- Ultrafiltration
- Nanofiltration
- Reverse Osmosis
- Others
Applications
- Pharmaceutical
- Biopharmaceutical
- Life Science
Companies covered
- Cytiva
- Merck Millipore
- Pall Corporation
- 3M
- Sartorius Group
- Thermo Fisher Scientific
- DuPont
- Parker Hannifin
- Koch Separation Solutions
- Amazon Filters
- Advantec
- Microdyn-Nadir
- Membrane Solutions
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Membrane Technology in Pharmaceutical Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Membrane Technology in Pharmaceutical Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Membrane Technology in Pharmaceutical Market Dynamics
- 2.1 Membrane Technology in Pharmaceutical Industry Trends
- 2.2 Membrane Technology in Pharmaceutical Industry Drivers
- 2.3 Membrane Technology in Pharmaceutical Industry Opportunities and Challenges
- 2.4 Membrane Technology in Pharmaceutical Industry Restraints
3 Membrane Technology in Pharmaceutical Market by Company
- 3.1 Global Membrane Technology in Pharmaceutical Company Revenue Ranking in 2025
- 3.2 Global Membrane Technology in Pharmaceutical Revenue by Company (2021-2026)
- 3.3 Global Membrane Technology in Pharmaceutical Company Ranking (2024-2026)
- 3.4 Global Membrane Technology in Pharmaceutical Company Manufacturing Base and Headquarters
- 3.5 Global Membrane Technology in Pharmaceutical Company Product Type and Application
- 3.6 Global Membrane Technology in Pharmaceutical Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Membrane Technology in Pharmaceutical Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Membrane Technology in Pharmaceutical Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Membrane Technology in Pharmaceutical Market by Type
- 4.1 Membrane Technology in Pharmaceutical Type Introduction
- 4.1.1 Microfiltration
- 4.1.2 Ultrafiltration
- 4.1.3 Nanofiltration
- 4.1.4 Reverse Osmosis
- 4.1.5 Others
- 4.2 Global Membrane Technology in Pharmaceutical Sales Value by Type
- 4.2.1 Global Membrane Technology in Pharmaceutical Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Membrane Technology in Pharmaceutical Sales Value by Type (2021-2032)
- 4.2.3 Global Membrane Technology in Pharmaceutical Sales Value Share by Type (2021-2032)
5 Membrane Technology in Pharmaceutical Market by Application
- 5.1 Membrane Technology in Pharmaceutical Application Introduction
- 5.1.1 Pharmaceutical
- 5.1.2 Biopharmaceutical
- 5.1.3 Life Science
- 5.2 Global Membrane Technology in Pharmaceutical Sales Value by Application
- 5.2.1 Global Membrane Technology in Pharmaceutical Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Membrane Technology in Pharmaceutical Sales Value by Application (2021-2032)
- 5.2.3 Global Membrane Technology in Pharmaceutical Sales Value Share by Application (2021-2032)
6 Membrane Technology in Pharmaceutical Regional Value Analysis
- 6.1 Global Membrane Technology in Pharmaceutical Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Membrane Technology in Pharmaceutical Sales Value by Region (2021-2032)
- 6.2.1 Global Membrane Technology in Pharmaceutical Sales Value by Region: 2021-2026
- 6.2.2 Global Membrane Technology in Pharmaceutical Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Membrane Technology in Pharmaceutical Sales Value (2021-2032)
- 6.3.2 North America Membrane Technology in Pharmaceutical Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Membrane Technology in Pharmaceutical Sales Value (2021-2032)
- 6.4.2 Europe Membrane Technology in Pharmaceutical Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Membrane Technology in Pharmaceutical Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Membrane Technology in Pharmaceutical Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Membrane Technology in Pharmaceutical Sales Value (2021-2032)
- 6.6.2 South America Membrane Technology in Pharmaceutical Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Membrane Technology in Pharmaceutical Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Membrane Technology in Pharmaceutical Sales Value Share by Country, 2025 VS 2032
7 Membrane Technology in Pharmaceutical Country-level Value Analysis
- 7.1 Global Membrane Technology in Pharmaceutical Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Membrane Technology in Pharmaceutical Sales Value by Country (2021-2032)
- 7.2.1 Global Membrane Technology in Pharmaceutical Sales Value by Country (2021-2026)
- 7.2.2 Global Membrane Technology in Pharmaceutical Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Membrane Technology in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Membrane Technology in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Membrane Technology in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Membrane Technology in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Membrane Technology in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Membrane Technology in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Membrane Technology in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Membrane Technology in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Membrane Technology in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Membrane Technology in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Membrane Technology in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Membrane Technology in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Membrane Technology in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.7.2 France Membrane Technology in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Membrane Technology in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Membrane Technology in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Membrane Technology in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Membrane Technology in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Membrane Technology in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Membrane Technology in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Membrane Technology in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Membrane Technology in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Membrane Technology in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Membrane Technology in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Membrane Technology in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Membrane Technology in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Membrane Technology in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Membrane Technology in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Membrane Technology in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Membrane Technology in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Membrane Technology in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Membrane Technology in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Membrane Technology in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Membrane Technology in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.14.2 China Membrane Technology in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Membrane Technology in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Membrane Technology in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Membrane Technology in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Membrane Technology in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Membrane Technology in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Membrane Technology in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Membrane Technology in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Membrane Technology in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.17.2 India Membrane Technology in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Membrane Technology in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Membrane Technology in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Membrane Technology in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Membrane Technology in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Membrane Technology in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Membrane Technology in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Membrane Technology in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Membrane Technology in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Membrane Technology in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Membrane Technology in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Membrane Technology in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Membrane Technology in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Membrane Technology in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Membrane Technology in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Membrane Technology in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Membrane Technology in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Membrane Technology in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Membrane Technology in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Membrane Technology in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Membrane Technology in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Membrane Technology in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Membrane Technology in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Membrane Technology in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Membrane Technology in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Membrane Technology in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Membrane Technology in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Membrane Technology in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Membrane Technology in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Membrane Technology in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Membrane Technology in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Membrane Technology in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Membrane Technology in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Membrane Technology in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Membrane Technology in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Membrane Technology in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Membrane Technology in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Membrane Technology in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Membrane Technology in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Membrane Technology in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Membrane Technology in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Cytiva
- 8.1.1 Cytiva Company Information
- 8.1.2 Cytiva Business Overview
- 8.1.3 Cytiva Membrane Technology in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 8.1.4 Cytiva Membrane Technology in Pharmaceutical Product Portfolio
- 8.1.5 Cytiva Recent Developments
- 8.2 Merck Millipore
- 8.2.1 Merck Millipore Company Information
- 8.2.2 Merck Millipore Business Overview
- 8.2.3 Merck Millipore Membrane Technology in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 8.2.4 Merck Millipore Membrane Technology in Pharmaceutical Product Portfolio
- 8.2.5 Merck Millipore Recent Developments
- 8.3 Pall Corporation
- 8.3.1 Pall Corporation Company Information
- 8.3.2 Pall Corporation Business Overview
- 8.3.3 Pall Corporation Membrane Technology in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 8.3.4 Pall Corporation Membrane Technology in Pharmaceutical Product Portfolio
- 8.3.5 Pall Corporation Recent Developments
- 8.4 3M
- 8.4.1 3M Company Information
- 8.4.2 3M Business Overview
- 8.4.3 3M Membrane Technology in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 8.4.4 3M Membrane Technology in Pharmaceutical Product Portfolio
- 8.4.5 3M Recent Developments
- 8.5 Sartorius Group
- 8.5.1 Sartorius Group Company Information
- 8.5.2 Sartorius Group Business Overview
- 8.5.3 Sartorius Group Membrane Technology in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 8.5.4 Sartorius Group Membrane Technology in Pharmaceutical Product Portfolio
- 8.5.5 Sartorius Group Recent Developments
- 8.6 Thermo Fisher Scientific
- 8.6.1 Thermo Fisher Scientific Company Information
- 8.6.2 Thermo Fisher Scientific Business Overview
- 8.6.3 Thermo Fisher Scientific Membrane Technology in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 8.6.4 Thermo Fisher Scientific Membrane Technology in Pharmaceutical Product Portfolio
- 8.6.5 Thermo Fisher Scientific Recent Developments
- 8.7 DuPont
- 8.7.1 DuPont Company Information
- 8.7.2 DuPont Business Overview
- 8.7.3 DuPont Membrane Technology in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 8.7.4 DuPont Membrane Technology in Pharmaceutical Product Portfolio
- 8.7.5 DuPont Recent Developments
- 8.8 Parker Hannifin
- 8.8.1 Parker Hannifin Company Information
- 8.8.2 Parker Hannifin Business Overview
- 8.8.3 Parker Hannifin Membrane Technology in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 8.8.4 Parker Hannifin Membrane Technology in Pharmaceutical Product Portfolio
- 8.8.5 Parker Hannifin Recent Developments
- 8.9 Koch Separation Solutions
- 8.9.1 Koch Separation Solutions Company Information
- 8.9.2 Koch Separation Solutions Business Overview
- 8.9.3 Koch Separation Solutions Membrane Technology in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 8.9.4 Koch Separation Solutions Membrane Technology in Pharmaceutical Product Portfolio
- 8.9.5 Koch Separation Solutions Recent Developments
- 8.10 Amazon Filters
- 8.10.1 Amazon Filters Company Information
- 8.10.2 Amazon Filters Business Overview
- 8.10.3 Amazon Filters Membrane Technology in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 8.10.4 Amazon Filters Membrane Technology in Pharmaceutical Product Portfolio
- 8.10.5 Amazon Filters Recent Developments
- 8.11 Advantec
- 8.11.1 Advantec Company Information
- 8.11.2 Advantec Business Overview
- 8.11.3 Advantec Membrane Technology in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 8.11.4 Advantec Membrane Technology in Pharmaceutical Product Portfolio
- 8.11.5 Advantec Recent Developments
- 8.12 Microdyn-Nadir
- 8.12.1 Microdyn-Nadir Company Information
- 8.12.2 Microdyn-Nadir Business Overview
- 8.12.3 Microdyn-Nadir Membrane Technology in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 8.12.4 Microdyn-Nadir Membrane Technology in Pharmaceutical Product Portfolio
- 8.12.5 Microdyn-Nadir Recent Developments
- 8.13 Membrane Solutions
- 8.13.1 Membrane Solutions Company Information
- 8.13.2 Membrane Solutions Business Overview
- 8.13.3 Membrane Solutions Membrane Technology in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 8.13.4 Membrane Solutions Membrane Technology in Pharmaceutical Product Portfolio
- 8.13.5 Membrane Solutions Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst